These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6382973)

  • 21. [Long-term drug therapy in inflammatory rheumatic diseases using chronic polyarthritis as an example. 2. Basic principles of long-term drug therapy: choice of optimal therapeutic agents].
    Menninger H; Burkhardt H
    Fortschr Med; 1983 Apr; 101(14):639-45. PubMed ID: 6406333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Basic treatment of rheumatoid arthritis].
    Domljan Z
    Reumatizam; 1974; 21(3):96-101. PubMed ID: 4831520
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug treatment in rheumatoid arthritis.
    Jayakar VV; Tilve GH
    J Indian Med Assoc; 1980 Jan; 74(2):38-40. PubMed ID: 7381220
    [No Abstract]   [Full Text] [Related]  

  • 24. Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis.
    Schiff MH; Whelton A
    Semin Arthritis Rheum; 2000 Dec; 30(3):196-208. PubMed ID: 11124283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disease-modifying antirheumatic drugs, including methotrexate, gold, sulfasalazine, antimalarials, and D-penicillamine.
    Conaghan PG; Brooks P
    Curr Opin Rheumatol; 1996 May; 8(3):176-82. PubMed ID: 8796975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Possible mechanism of action of drugs in the basic therapy of rheumatoid arthritis: effect on platelet aggregation].
    Fioravanti A; Lolatte V; Giordano N; Frati E; Castagna ML; Morozzi G; Lalumera M; Marcolongo R
    Boll Soc Ital Biol Sper; 1984 May; 60(5):1051-6. PubMed ID: 6432005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levamisole - a possible alternative to gold and penicillamine in the longterm treatment of rheumatoid arthritis?
    Capell HA; Hunter JA; Rennie JA; Murdoch RM
    J Rheumatol; 1981; 8(5):730-40. PubMed ID: 7310774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variations and trends in the prescription of initial second line therapy for patients with rheumatoid arthritis.
    Galindo-Rodriguez G; Avina-Zubieta JA; Fitzgerald A; LeClerq SA; Russell AS; Suarez-Almazor ME
    J Rheumatol; 1997 Apr; 24(4):633-8. PubMed ID: 9101493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R; Schleusser B; Herborn G; Karger T
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Some immunological changes in rheumatoid arthritis among patients receiving penicillamine and gold.
    Huskisson EC; Berry H
    Postgrad Med J; 1974 Aug; 50 Suppl 2():59-61. PubMed ID: 4467180
    [No Abstract]   [Full Text] [Related]  

  • 31. Penicillamine compared to previous chrysotherapy in rheumatoid arthritis.
    Stein HB; Ruedy J; Atkins CJ; Offer RC
    J Rheumatol; 1983 Apr; 10(2):319-22. PubMed ID: 6864688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drugs in the management of rheumatoid arthritis.
    Bresnihan B
    Ir Med J; 1982 Jan; 75(1):7-9. PubMed ID: 6806208
    [No Abstract]   [Full Text] [Related]  

  • 33. [Physiopathology of rheumatoid polyarthritis for today's and tomorrow's therapists].
    Amor B
    Rev Prat; 1986 Dec; 36(57):3407-12. PubMed ID: 3809942
    [No Abstract]   [Full Text] [Related]  

  • 34. Bronchoalveolar lavage and lung biopsy in rheumatoid arthritis. In vivo effects of disease modifying antirheumatic drugs.
    Scherak O; Popp W; Kolarz G; Wottawa A; Ritschka L; Braun O
    J Rheumatol; 1993 Jun; 20(6):944-9. PubMed ID: 8102405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of anti-malarials in rheumatoid arthritis--the American experience.
    Khraishi MM; Singh G
    Lupus; 1996 Jun; 5 Suppl 1():S41-4. PubMed ID: 8803910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Follow-up study of patients with rheumatoid arthritis over a period of more than 10 years (1966-1978): analysis of disease progression and treatment in 100 cases (author's transl)].
    Amor B; Herson D; Cherot A; Delbarre F
    Ann Med Interne (Paris); 1981; 132(3):168-73. PubMed ID: 7294583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defective monocyte accessory function due to surface sulphydryl (SH) oxidation in rheumatoid arthritis.
    McKeown MJ; Hall ND; Corvalan JR
    Clin Exp Immunol; 1984 Jun; 56(3):607-13. PubMed ID: 6744663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapy of chronic polyarthritis. 1. Causal therapy, basic drug therapy].
    Mathies H
    Fortschr Med; 1972 Aug; 90(24):852-6 contd. PubMed ID: 4639348
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparative studies on the immunodepressive effect of D-penicillamine and gold salts in chronic progressive polyarhtritis].
    Miehlke K; Kohlhardt I; Wirth B
    Z Rheumaforsch; 1968 Dec; 27(11):445-54. PubMed ID: 5710880
    [No Abstract]   [Full Text] [Related]  

  • 40. Combined disease-modifying chemotherapy for intractable rheumatoid arthritis.
    Bitter T
    Clin Rheum Dis; 1984 Aug; 10(2):417-28. PubMed ID: 6391796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.